Non‐reproductive effects of follicle‐stimulating hormone in young men
Andrology · 2023
DOI: 10.1111/andr.13335 ↗At a glance
Randomisierte kontrollierte Studie in Andrology, 2023. Written by Angel Elenkov and 5 co-authors. Institution: Reproductive Medicine Centre, Skane University Hospital Malmo, Malmö, Sweden. Major MEDLINE topics: Follicle Stimulating Hormone, Follicle Stimulating Hormone, Human. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Objective
Follicle‐stimulating hormone (FSH) receptor expression has been reported in many extra‐gonadal tissues, raising the question of non‐reproductive effects of FSH. Because of increasing usage of FSH in treatment of male infertility, deeper knowledge of possible harmful off‐target effects of FSH is warranted.
Methods
In total, 33 healthy young men (mean age 30 years) were included in the study. All received an s.c. injection of gonadotropin‐releasing hormone (GnRH) antagonist and n = 16 were randomized to 300 IU recombinant FSH (300 IE 3 times/week) for 5 weeks at first visit (V1) whereas n = 17 served as controls. Blood samples were taken at (V1), after 3 weeks (V2), and after 5 weeks (V3), when the study ended. At V2, all subjects received 1000 mg testosterone undecanoate i.m. A standard set of bio‐ and inflammatory markers were compared between the groups using the Mann–Whitney test adjusted for multiple testing.
Results
As compared to controls, the FSH treated men had higher SHBG and albumin concentrations at V2 ( p = 0.024 and 0.027, respectively), and lower levels of alanine aminotransferase ( p = 0.026) and magnesium ( p = 0.028) at V3. However, none of the results remained statistically significant after Bonferroni correction ( p > 0.0011).
Conclusions
FSH had no significant effects on non‐reproductive organs when given in standard therapeutic doses to young men for 5 weeks. Therefore, the FSH treatment can be considered safe in otherwise healthy young men, constituting candidates for the infertility treatment with FSH.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Reproductive Medicine Centre, Skane University Hospital Malmo, Malmö, Sweden.
- Department of Translational Medicine, Lund University, Lund, Sweden.
ORCID profiles: Aleksander Giwercman
Cite
APA
Elenkov, A., Wirestrand, E., Hagsund, A., Huhtaniemi, I., Giwercman, Y. L., & Giwercman, A. (2023). Non‐reproductive effects of follicle‐stimulating hormone in young men. Andrology. https://doi.org/10.1111/andr.13335
Vancouver
Elenkov A, Wirestrand E, Hagsund A, Huhtaniemi I, Giwercman YL, Giwercman A. Non‐reproductive effects of follicle‐stimulating hormone in young men. Andrology. 2023. doi:10.1111/andr.13335
BibTeX
@article{Elenkov2023,
author = {Elenkov, Angel and Wirestrand, Elin and Hagsund, Agnes and Huhtaniemi, Ilpo and Giwercman, Yvonne Lundberg and Giwercman, Aleksander},
title = {Non‐reproductive effects of follicle‐stimulating hormone in young men},
journal = {Andrology},
year = {2023},
doi = {10.1111/andr.13335}
}
EUVIMED